Plumbline Life Sciences Overview

  • Year Founded
  • 2014

Year Founded

  • Status
  • Public

  • Employees
  • 4

Employees

  • Stock Symbol
  • 222670

Stock Symbol

  • Investments
  • 1

  • Share Price
  • $3.21
  • (As of Thursday Closing)

Plumbline Life Sciences General Information

Description

Plumbline Life Sciences Inc is a bio-animal health company. The company provides Dog cancer treatment, such as pig DNA Therapy. It provides curing for animals and healing for humans.

Contact Information

Website
www.plsdna.com
Ownership Status
Publicly Held
Financing Status
Corporation
Corporate Office
  • Room 1315, Songeui Multiplex Hall
  • College of Medicine, The Catholic University of Korea, 222 Banpo-daero
  • Seocho-gu, Seoul
  • South Korea
Primary Industry
Other Commercial Services
Other Industries
Other Commercial Products
Stock Exchange
KRX
Vertical(s)
Corporate Office
  • Room 1315, Songeui Multiplex Hall
  • College of Medicine, The Catholic University of Korea, 222 Banpo-daero
  • Seocho-gu, Seoul
  • South Korea

Plumbline Life Sciences Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Plumbline Life Sciences Stock Performance

As of 19-Feb-2026, Plumbline Life Sciences’s stock price is $3.21. Its current market cap is $11M with 3.42M shares.

(As of Thursday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$3.21 $3.25 $2.54 - $6.18 $11M 3.42M 2.31K -$0.50

Plumbline Life Sciences Financials Summary

As of 31-Dec-2025, Plumbline Life Sciences has a trailing 12-month revenue of $13.5K.

In Thousands,
USD
TTM 31-Dec-2025 FY 2025 31-Dec-2025 FY 2024 31-Dec-2024
EV 13,259 13,259
Revenue 13 13
EBITDA (733) (733) (1,002)
Net Income (1,006) (1,006) (1,486)
Total Assets 1,982 1,982 1,543
Total Debt 645 645 1,085
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Plumbline Life Sciences Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Plumbline Life Sciences‘s full profile, request access.

Request a free trial

Plumbline Life Sciences Patents

Plumbline Life Sciences Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
CA-3181812-A1 African swine fever vaccine composition Pending 14-Apr-2020
EP-4137506-A1 African swine fever vaccine composition Pending 14-Apr-2020
EP-4137506-A4 African swine fever vaccine composition Pending 14-Apr-2020
JP-2023522053-A African swine fever vaccine composition Active 14-Apr-2020
JP-7905103-B2 African swine fever vaccine composition Active 14-Apr-2020 A61P31/20
To view Plumbline Life Sciences’s complete patent history, request access »

Plumbline Life Sciences Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Plumbline Life Sciences Acquisitions (1)

Plumbline Life Sciences’s most recent deal was a Merger/Acquisition with VGX Animal Health for . The deal was made on 27-May-2014.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
VGX Animal Health 27-May-2014 Merger/Acquisition Other Commercial Products
To view Plumbline Life Sciences’s complete acquisitions history, request access »

Plumbline Life Sciences ESG

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

Rank

Percentile

Pharmaceuticals

Industry

Rank

Percentile

Pharmaceuticals

Subindustry

Rank

Percentile

To view Plumbline Life Sciences’s complete esg history, request access »

Plumbline Life Sciences FAQs

  • When was Plumbline Life Sciences founded?

    Plumbline Life Sciences was founded in 2014.

  • Where is Plumbline Life Sciences headquartered?

    Plumbline Life Sciences is headquartered in Seocho-gu, South Korea.

  • What is the size of Plumbline Life Sciences?

    Plumbline Life Sciences has 4 total employees.

  • What industry is Plumbline Life Sciences in?

    Plumbline Life Sciences’s primary industry is Other Commercial Services.

  • Is Plumbline Life Sciences a private or public company?

    Plumbline Life Sciences is a Public company.

  • What is Plumbline Life Sciences’s stock symbol?

    The ticker symbol for Plumbline Life Sciences is 222670.

  • What is the current stock price of Plumbline Life Sciences?

    As of 19-Feb-2026 the stock price of Plumbline Life Sciences is $3.21.

  • What is the current market cap of Plumbline Life Sciences?

    The current market capitalization of Plumbline Life Sciences is $11M.

  • What is Plumbline Life Sciences’s current revenue?

    The trailing twelve month revenue for Plumbline Life Sciences is $13.5K.

  • What is Plumbline Life Sciences’s annual earnings per share (EPS)?

    Plumbline Life Sciences’s EPS for 12 months was -$0.50.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process